Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
ABL Bio (South Korea)
h-index: 11
Total citations: 446
Total papers: 56
Homepage:
http://ablbio.com/
Recent papers from ABL Bio (South Korea)
Preclinical development of ABL206, a novel bispecific antibody-drug conjugate targeting B7-H3 and ROR1
mAbs · 2026
Harnessing Gradient Topography and Dual‐Mode Bioactive Delivery via Bone‐Adhesive Exosome Mimetics for Rotator Cuff Tendon–Bone Interface Repair
Small · 2026
ABL209 (NEOK002) : Designing an EGFRxMUC1 bispecific TOP1i ADC with promising anti-tumor activity and enhanced therapeutic window
Molecular Cancer Therapeutics · 2026
Abstract 1726: NEOK002 (ABL209): Redesigning an EGFRxMUC1 bispecific TOP1i ADC with promising anti-tumor activity and enhanced therapeutic window
Cancer Research · 2026
Abstract 1724: NEOK001 (ABL206): A first in class B7-H3xROR1 bispecific ADC demonstrated enhanced efficacy and promising tolerability
Cancer Research · 2026
Clinical-Grade Human Induced Pluripotent Stem Cell-Derived Neural Precursor Cells Restore Motor Function and Preserve Striatal Integrity in a Quinolinic Acid-Lesioned Rat Model of Huntington's Disease.
2026
Expanding the horizons of cancer therapy with next-generation 4-1BB agonists: a review of molecular and clinical strategies to maximize efficacy and ensure safety.
2026
A brain-shuttled antibody targeting alpha synuclein aggregates for the treatment of synucleinopathies
npj Parkinson s Disease · 2025
The effects of candidate probiotic strains on the gut environment in dextran sulfate sodium-induced colitis mouse
Scientific Reports · 2025
A First-in-Human Study of Givastomig, a CLDN18.2 and 4-1BB Bispecific Antibody, as Monotherapy in Patients with CLDN18.2-Positive Advanced or Metastatic Solid Tumors
Clinical Cancer Research · 2025
Differential polyamine metabolism in CHO cell lines: Insights into cell growth and antibody quality
New Biotechnology · 2025
Phase 2 Study Design and Analysis Approach for BBT-877: An Autotaxin Inhibitor Targeting Idiopathic Pulmonary Fibrosis
2025
CLEC12A-directed immunocytokine with target cell–restricted IL-15 activity for treatment of acute myeloid leukemia
Frontiers in Immunology · 2025
Neoagarooligosaccharides improve non-alcoholic fatty liver disease by modulating lipid metabolism and Nrf2-related pathways
Journal of Functional Foods · 2025
Fc-competent TIGITx4-1BB bispecific antibody exerts potent long-lasting antitumor activity by potentiating CD8 ⁺ T cell activity and Fcγ receptor-mediated modulation of the tumor microenvironment
Journal for ImmunoTherapy of Cancer · 2025
A brain-shuttled antibody targeting alpha synuclein aggregates for the treatment of synucleinopathies
2024
Population pharmacokinetic model of ABL001/CTX‐009 (anti‐VEGF/DLL4) in adult cancer patients with solid tumor
Cancer Science · 2024
Phase 1 trial safety and efficacy of ragistomig, a bispecific antibody targeting PD-L1 and 4-1BB, in advanced solid tumors.
Journal of Clinical Oncology · 2024
Anti–4-1BB×PDL1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD1 Blockade
Clinical Cancer Research · 2024
Abstract 6354: The HER2/4-1BB bispecific antibody, YH32367 (ABL105) demonstrates optimal efficacy and safety for HER2-expressing tumors and exhibits synergistic efficacy when combined with anti-PD-L1
Cancer Research · 2024